Valuation, from the filing
| Public float | $70.13M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-10-31 |
|---|---|---|
| Float per share | $24.43 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 7.3× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 0.2× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 0.9× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-10-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-04-30 — the year that filing covered.
Valuation over time
7.3× earnings today, against a median of 11.0× across 7 years on record. Below its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-10-31 | $70.13M | 7.3× | |
| 2024-10-31 | $53.99M | 4.7× | |
| 2023-10-31 | $26.98M | 1.4× | |
| 2022-10-31 | $37.91M | 51.4× | |
| 2018-10-31 | $71.66M | 46.9× | |
| 2017-10-31 | $63.72M | 12.1× | |
| 2016-10-31 | $49.76M | 11.0× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported revenue of $277.22M and net income of $8.23M for the fiscal year ended 2026-07-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from KEWAUNEE SCIENTIFIC CORP /DE/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-07-31 |
|---|---|
| Revenue | $277.22M |
| Cost of revenue | $198.07M |
| Gross profit | $79.15M |
| Operating income | $15.06M |
| Net income | $8.23M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $12.37M |
| Income tax expense | $3.22M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | Unavailable |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-07-31 |
|---|---|
| Cash & equivalents | $8.25M |
| Total assets | $175.80M |
| Current assets | $103.95M |
| Total liabilities | $98.58M |
| Current liabilities | $47.24M |
| Total equity incl. NCI | $77.22M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $29.79M |
| Accounts receivable | $58.20M |
| Goodwill | $12.49M |
| Long-term debt | $13.83M |
| Accounts payable | $21.56M |
Cash flow
| Metric | 2026-07-31 |
|---|---|
| Operating cash flow | $14.82M |
| Capital expenditures | Unavailable |
| Investing cash flow | -$3.94M |
| Financing cash flow | -$20.36M |
| Net change in cash | -$10.18M |
| Stock-based compensation | $3.50M |
| Common dividends paid | Unavailable |
| Common share repurchases | Unavailable |
| Depreciation & amortization | $6.32M |
Derived
| Metric | 2026-07-31 |
|---|---|
| Free cash flow | Unavailable |
| Gross margin | 28.6% |
| Operating margin | 5.4% |
| FCF margin | Unavailable |
| SBC / revenue | 1.3% |
| Current ratio | 2.20x |
| Revenue YoY growth | 5.3% |
| Net margin | 3.0% |
| R&D / revenue | Unavailable |
| CapEx / revenue | Unavailable |
| Long-term debt / equity | 0.18x |
| Effective tax rate | 26.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open KEQU in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.